Dear Dr. Roach: I recently read this morning that the shingles vaccine, Shingrix, "may have a protective effect against dementia." It goes on to say the studies that have been conducted so far are ...

DEAR DR. ROACH: I recently read this morning that the shingles vaccine, Shingrix, “may have a protective effect against dementia.” It goes on to say the studies that have been conducted so far are ...

KUALA LUMPUR, Malaysia, March 27, 2025 /PRNewswire/ -- Subang Jaya Medical Centre (SJMC) has achieved a significant milestone in patient care, becoming the first hospital in Asia-Pacific to hold four ...

GSK’s Shingrix new prefilled syringe presentation accepted for review by US FDA. News release. GSK. January 10, 2025.

The study’s key findings included: Shingrix was associated with 17 percent lower risk of dementia than Zostavax, and a 23 to 27 percent lower risk than other vaccines included in the study.

The Shingrix vaccine’s potential to reduce dementia risk is an exciting development. While further research is needed to fully understand the mechanisms, these findings underscore the broader ...

Shingrix is one of GSK’s best selling products, generating £3.4bn revenue worldwide in 2023. The new study added to the “growing body of evidence that suggests an association between ...

GSK's regulatory application for Shingrix for the prevention of shingles in at-risk adults aged 18 and over accepted for review by China National Medical Products Administration · Shingrix ...

However, Shingrix, a two-dose shingles vaccine that was approved by the Food and Drug Administration in 2017, can reduce the incidence of shingles and its complications significantly.

Issued: 26 June 2023, London UK Japan's Ministry of Health, Labour and Welfare approves Shingrix for the prevention of shingles in at-risk adults aged 18 and over · Approval expands the number of ...